China Meheco Group Co (SHSE:600056) Forward PE Ratio: 0.00 (As of Aug. 06, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600056 China Meheco Group Co Ltd SHSE:600056
65 GF Score
Price ¥9.34
GF Value ¥10.46
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is China Meheco Group Co Forward PE Ratio?

China Meheco Group Co SHSE:600056 +1.52% 65 Forward PE Ratio is 0.00 as of Aug. 06, 2026. GuruFocus rates SHSE:600056 with a GF Score™ of 65/100 and a GF Value™ of ¥10.46 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 50 Medical Distribution companies, China Meheco Group Co ranks worse than 1999998% on this metric.

China Meheco Group Co's Forward PE Ratio for today is 0.00.

China Meheco Group Co's PE Ratio without NRI for today is 19.70.

China Meheco Group Co's PE Ratio (TTM) for today is 28.92.


China Meheco Group Co  (SHSE:600056) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


China Meheco Group Co Forward PE Ratio Related Terms


China Meheco Group Co Forward PE Ratio Historical Data

* Premium members only.

The historical data trend for China Meheco Group Co's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China Meheco Group Co Forward PE Ratio Chart

China Meheco Group Co Annual Data
Trend
Forward PE Ratio

China Meheco Group Co Quarterly Data
Forward PE Ratio

SHSE:600056 vs MCK, COR, CAH: Forward PE Ratio Comparison

For the Medical Distribution subindustry, China Meheco Group Co's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Meheco Group Co Forward PE Ratio vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, China Meheco Group Co's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where China Meheco Group Co's Forward PE Ratio falls into.


SHSE:600056
65GF Score
China Meheco Group Co Ltd SHSE:600056
Forward PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

China Meheco Group Co Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.

Frequently Asked Questions Learn more about Forward PE Ratio →
What does a Forward PE Ratio of 0.00 mean?
China Meheco Group Co (SHSE:600056) has a Forward PE Ratio of 0.00 as of Aug. 06, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on China Meheco Group Co and its competitors. According to the industry distribution chart, China Meheco Group Co ranks #999999 out of 50 companies in the Medical Distribution industry.
Is China Meheco Group Co's Forward PE Ratio too high?
China Meheco Group Co's current Forward PE Ratio is 0.00. Based on the distribution chart, China Meheco Group Co ranks #999999 out of 50 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, China Meheco Group Co has a GF Score™ of 65/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does China Meheco Group Co's Forward PE Ratio compare to MCK and COR?
According to the Medical Distribution industry distribution chart, China Meheco Group Co ranks #999999 out of 50 companies for Forward PE Ratio. This places China Meheco Group Co in the lower half of its industry. The industry median Forward PE Ratio is 14.44. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Medical Distribution company?
The median Forward PE Ratio among Medical Distribution companies is 14.44, based on 50 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on China Meheco Group Co and its competitors. For the Medical Distribution industry, the median Forward PE Ratio is 14.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Meheco Group Co's current Forward PE Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Meheco Group Co stock overvalued right now?
Based on GuruFocus' analysis, China Meheco Group Co (SHSE:600056) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥10.46, compared to a current price of ¥9.34 — trading 10.7% below its estimated fair value. The current Forward PE Ratio is 0.00. China Meheco Group Co's overall GF Score™ is 65/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For China Meheco Group Co (SHSE:600056), the current Forward PE Ratio is 0.00 as of Aug. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is China Meheco Group Co (SHSE:600056) Overvalued in 2026?

Based on GuruFocus' analysis, China Meheco Group Co stock appears to be undervalued. The current stock price of ¥9.34 is trading 10.7% below its estimated GF Value™ of ¥10.46. GuruFocus considers China Meheco Group Co to be Modestly Undervalued.

Key valuation signals for SHSE:600056:

  • Forward PE Ratio: 0.00
  • GF Value™: ¥10.46 vs. price of ¥9.34 (10.7% below fair value)
  • GF Score™: 65/100 with 6 warning signs

No single metric tells the full story. See the SHSE:600056 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


China Meheco Group Co Business Description

Address No. 1 Xiying Street, Floor 18-28, Block B, Building 1, General Times Center, District 1, Fengtai, Beijing, CHN, 100073
China Meheco Group Co Ltd is engaged in the distribution and trading of botanical medicines, medical instruments, and pharmaceuticals. It offers botanic medicines and herbal products, as well as exports of natural medicines, including herbs, spices, plant extracts, bee products, and Chinese traditional medicines. The company's business scope covers the whole industry chain, from research and development, cultivation and processing, manufacturing, distribution, and logistics to international trading, academic promotion, and technical service. The corporation provides trading services for customers in the pharmaceutical and chemical field, covering APIs, preparations, biologicals, blood products, and others.
65GF Score

Get the complete analysis for SHSE:600056

Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥9.34
Price
¥10.46
GF Value